Buformin hydrochloride

This classification denotes an anti-diabetic agent with the molecular formula C6H15N5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D947SXO87P, chemically known as imidodicarbonimidic diamide, n-butyl- but more generally known as buformin hydrochloride, which bears US NIH Compound Identifier 2468. European Medicines Agency schedules Buformin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00892MIG. Most nations, for tariff and trade purposes, schedule buformin hydrochloride under HS 29252900 and SITC 51482. As of Q4 2014, BUFORMIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Buformin hydrochloride bears US NLM identifiers UMLS ID C2987056 and NCI Concept Code C95329. SMILES: CCCCNC(=N)NC(=N)N.CL.